C19H21N7O2
Neat
379.42
Cyanoacetyl Tofacitinib; 3-(4-(((3R, 4R)-1-(2-Cyanoacetyl)-4-methylpiperidin-3-yl)(methyl)amino)-7H-pyrrolo[2, 3-d]pyrimidin-7-yl)-3-oxopropanenitrile; 2459302-77-1; Tofacitinib Impurity 15; V3GM9K9YRR; SCHEMBL28413800; 4-[[(3R, 4R)-1-(2-Cyanoacetyl)-4-methyl-3-piperidinyl]methylamino]-beta-oxo-7H-pyrrolo[2, 3-d]pyrimidine-7-propanenitrile; 7H-Pyrrolo[2, 3-d]pyrimidine-7-propanenitrile, 4-[[(3R and 4R)-1-(2-cyanoacetyl)-4-methyl-3-piperidinyl]methylamino]-beta-oxo-
3-[(3R, 4R)-3-[[7-(2-cyanoacetyl)pyrrolo[2 and 3-d]pyrimidin-4-yl]-methylamino]-4-methylpiperidin-1-yl]-3-oxopropanenitrile
InChI=1S/C19H21N7O2/c1-13-5-9-25(16(27)3-7-20)11-15(13)24(2)18-14-6-10-26(17(28)4-8-21)19(14)23-12-22-18/h6,10,12-13,15H,3-5,9,11H2,1-2H3/t13-,15+/m1/s1